ライフサイエンスコーパス: review board

1 iant study was approved by the institutional review board.

2 tive study was approved by the institutional review board.

3 consent under approval of the institutional review board.

4 tive study was approved by the institutional review board.

5 trol study was approved by the institutional review board.

6 tive study was approved by the institutional review board.

7 with HIPAA and approved by the institutional review board.

8 iant study was approved by the institutional review board.

9 mpliant study was exempted from the internal review board.

10 compliant and approved by the institutional review board.

11 a-analysis was approved by the institutional review board.

12 tive study was approved by the institutional review board.

13 This study was approved by the institutional review board.

14 The study was approved by the institutional review board.

15 tudy was approved by the local institutional review board.

16 tive study was approved by the institutional review board.

17 was approved by the university institutional review board.

18 with HIPAA and approved by the institutional review board.

19 hods Approval was obtained from the regional review board.

20 nth period and approved by the institutional review board.

21 iant study was approved by the institutional review board.

22 tive study was approved by the institutional review board.

23 care and use committee and the institutional review board.

24 This study was approved by the institutional review board.

25 l animal studies committee and institutional review board.

26 iant study was approved by the institutional review board.

27 iant study was approved by the institutional review board.

28 After approval by the institutional review board, 1,022 LNs in the PET/CT examinations of 14

29 This study was approved by the institutional review board and all participants gave informed consent.

30 This study was approved by the institutional review board and by national government authorities.

31 This study was approved by the institutional review board and compliant with HIPAA and included BCSC

32 tive study was approved by the institutional review board and compliant with HIPAA.

33 tive study was approved by the institutional review board and compliant with HIPAA.

34 tive study was approved by the institutional review board and compliant with HIPAA.

35 tive study was approved by the institutional review board and compliant with HIPAA.

36 This study was approved by the institutional review board and compliant with HIPAA.

37 This study was approved by the institutional review board and compliant with HIPAA.

38 onal study was approved by the institutional review board and compliant with HIPAA.

39 This study was approved by the institutional review board and complied with HIPAA.

40 ementation were overseen by an institutional review board and conformed to HIPAA guidelines on patien

41 Materials and Methods Institutional review board and informed consent were waived for this s

42 tional Military Medical Center institutional review board and is compliant with HIPAA guidelines.

43 tional Military Medical Center institutional review board and is compliant with HIPAA guidelines.

44 Materials and Methods Institutional review board and local ethics committee approval and wri

45 The study was approved by the institutional review board and local ethics committee.

46 s compliant with HIPAA and the institutional review board and required written consent from the parti

47 stem cells was approved by the institutional review board and the stem cell research oversight commit

48 hort study was approved by the institutional review board and was compliant with HIPAA.

49 spective study approved by the institutional review board and was HIPAA compliant with waiver of info

50 The study was approved by the institutional review board and written informed consent with HIPAA aut

51 tive study was approved by the institutional review boards and compliant with HIPAA.

52 ablishing common protocols for institutional review boards and data sharing, creating protocols for r

53 y protocol was approved by the institutional review boards and was HIPAA compliant.

54 The study was approved by the institutional review board, and all participants gave informed consent

55 This study was approved by the institutional review board, and all participants gave written informed

56 This study was approved by the institutional review board, and all subjects gave signed informed cons

57 tudy was approved by the local institutional review board, and informed consent was obtained from all

58 prospective study was approved by the ethics review board, and informed consent was obtained.

59 tive study was approved by the institutional review board, and informed consent was waived.

60 tive study was approved by the institutional review board, and the requirement for informed consent w

61 tive study was approved by the institutional review board, and the requirement for informed consent w

62 tive study was approved by the institutional review board, and the requirement to obtain informed con

63 tive study was approved by the institutional review board, and the requirement to obtain informed con

64 etrospective study was approved by an ethics review board, and the requirement to obtain informed wri

65 This study was approved by the institutional review board, and written informed consent was obtained

66 tive study was approved by the institutional review board, and written informed consent was obtained.

67 onal study was approved by the institutional review boards, and all participants gave informed consen

68 tive study was approved by the institutional review boards, and written informed consent was obtained

69 terials and Methods This is an institutional review board- and U.S. Food and Drug Administration-appr

70 esignation and is exempt from Human Subjects Review Board approval (11-DRDS-NR03).

71 and Methods The study received institutional review board approval and all patients gave written info

72 his prospective study received institutional review board approval and fully complied with HIPAA regu

73 Materials and Methods With institutional review board approval and Health Insurance Portability a

74 Materials and Methods Institutional review board approval and informed consent were obtained

75 Materials and Methods Institutional review board approval and informed consent were obtained

76 aterials and Methods Following institutional review board approval and informed consent, 26 subjects

77 After institutional review board approval and informed consent, consecutive

78 als and Methods This study had institutional review board approval and was HIPAA compliant.

79 Materials and Methods Institutional review board approval and written informed consent from

80 Institutional review board approval and written informed consent from

81 Materials and Methods Institutional review board approval and written informed consent were

82 Materials and Methods Institutional review board approval and written informed consent were

83 Institutional review board approval and written informed consent were

84 Materials and Methods Institutional review board approval and written informed consent were

85 tudy was HIPAA compliant, with institutional review board approval and written informed consent.

86 Materials and Methods Institutional review board approval and written informed patient conse

87 ctal liver metastases, whereas institutional review board approval is required before glass microsphe

88 Methods In accordance with the institutional review board approval obtained at the two participating

89 tional new drug submission and institutional review board approval standards.

90 Materials and Methods Institutional review board approval was given and patient consent was

91 ation was accessed; therefore, institutional review board approval was not sought.

92 Institutional review board approval was obtained and informed consent

93 Materials and Methods Institutional review board approval was obtained and informed consent

94 Materials and Methods Institutional review board approval was obtained and the requirement f

95 Materials and Methods Institutional review board approval was obtained for active or passive

96 Materials and Methods Institutional review board approval was obtained for this HIPAA-compli

97 Materials and Methods Institutional review board approval was obtained for this HIPAA-compli

98 Materials and Methods Institutional review board approval was obtained for this HIPAA-compli

99 Materials and Methods Institutional review board approval was obtained for this HIPAA-compli

100 Materials and Methods Institutional review board approval was obtained for this prospective

101 Materials and Methods Institutional review board approval was obtained for this retrospectiv

102 Materials and Methods Institutional review board approval was obtained for this study; all p

103 Materials and Methods Institutional review board approval was obtained from Leipzig Universi

104 Materials and Methods Institutional review board approval was obtained with waiver of consen

105 Materials and Methods Institutional review board approval was obtained, and informed consent

106 Institutional review board approval was obtained, and informed consent

107 Materials and Methods Institutional review board approval was obtained, and informed consent

108 Materials and Methods Institutional review board approval was obtained, and patient consent

109 Materials and Methods Institutional review board approval was obtained, and the requirement

110 Materials and Methods Review board approval was obtained, with waiver of infor

111 Materials and Methods Institutional review board approval was obtained, with waiver of infor

112 Institutional review board approval was obtained, with waiver of the n

113 iver of informed consent after institutional review board approval was obtained.

114 Materials and Methods Institutional review board approval was obtained.

115 Materials and Methods Institutional review board approval was obtained.

116 Institutional review board approval was obtained.

117 in U.S. Materials and Methods Institutional review board approval was waived, as the study used publ

118 HISTORY: Materials and Methods Institutional review board approval was waived, as the study used publ

119 After institutional review board approval with a waiver of informed consent

120 nd Methods This study received institutional review board approval with waiver of consent.

121 nter HIPAA-compliant study had institutional review board approval, and all participants gave written

122 als and Methods This study had institutional review board approval, and informed consent was obtained

123 This HIPAA-compliant study had institutional review board approval, and informed consent was obtained

124 nd Methods This study received institutional review board approval, and patients gave informed consen

125 and Methods The study received institutional review board approval, and patients in the CLQ cohort pr

126 This HIPAA-compliant study had institutional review board approval, and the need for informed consent

127 s This retrospective study had institutional review board approval, and the need to obtain informed p

128 taining antemortem consent and institutional review board approval, the authors compared postmortem n

129 With institutional review board approval, we searched our prospectively acq

130 Materials and Methods Institutional review board approval, with a waiver of informed consent

131 s retrospective study received institutional review board approval, with a waiver of the HIPAA requir

132 aterials and Methods Following institutional review board approval, with waiver of consent and with H

133 e database were evaluated with institutional review board approval.

134 tive study was completed after institutional review board approval.

135 eers with informed consent and institutional review board approval.

136 and is, therefore, exempt from institutional review board approval.

137 nce with HIPAA regulations and institutional review board approval.

138 ectional study was exempt from institutional review board approval.

139 s This retrospective study had institutional review board approval; written informed consent was obta

140 als and Methods This study was institutional review board approved and HIPAA compliant.

141 This study was institutional review board approved and HIPAA compliant.

142 This retrospective study was institutional review board approved and HIPAA compliant; informed cons

143 Each institutional review board approved the prospective study protocol, an

144 The institutional review board approved the study and all participants pro

145 The local institutional review board approved the study, and all participants ga

146 Materials and Methods The institutional review board approved the study.

147 Materials and Methods The institutional review board approved this cross-sectional study.

148 aterials and Methods The local institutional review board approved this HIPAA-compliant retrospective

149 Materials and Methods The institutional review board approved this prospective Health Insurance

150 Materials and Methods The institutional review board approved this prospective hypotheses-genera

151 The institutional review board approved this prospective study.

152 Materials and Methods The institutional review board approved this prospective, HIPAA-compliant,

153 The institutional review board approved this retrospective chart review st

154 Materials and Methods The institutional review board approved this retrospective cohort study, w

155 Materials and Methods The institutional review board approved this retrospective HIPAA-compliant

156 Materials and Methods The institutional review board approved this retrospective study and infor

157 Materials and Methods An institutional review board approved this retrospective study and waive

158 Materials and Methods The institutional review board approved this retrospective study of 31 pat

159 The institutional review board approved this retrospective study of 403 pa

160 Materials and Methods Institutional review board approved this retrospective study, with wai

161 Materials and Methods The institutional review board approved this retrospective study, with wai

162 The institutional review board approved this study and waived the need for

163 Materials and Methods The institutional review board approved this study.

164 This study was retrospective, institutional review board approved, and HIPAA compliant.

165 This retrospective study was Institutional Review Board approved, and informed consent was waived.

166 Materials and Methods This institutional review board approved, HIPAA-compliant retrospective rev

167 ompliant prospective study was institutional review board approved.

168 This retrospective study was institutional review board approved.

169 is study was HIPAA compliant and institution review board approved.

170 This study was institutional review board approved; the need for signed informed cons

171 als and Methods The respective institutional review boards approved this HIPAA-compliant study and wa

172 rials and Methods The relevant institutional review boards approved this HIPAA-compliant study, with

173 The applicable institutional review boards approved this study, and all participants

174 ods This prospective study was institutional review board- approved and HIPAA compliant.

175 In this institutional review board-approved and Health Insurance Portability a

176 Materials and Methods In this institutional review board-approved and HIPAA-compliant protocol, 408

177 erials and Methods This was an institutional review board-approved and HIPAA-compliant retrospective

178 aterials and Methods This was an intuitional review board-approved and HIPAA-compliant retrospective

179 e enrolled in this prospective institutional review board-approved and HIPAA-compliant study between

180 Materials and Methods This institutional review board-approved and HIPAA-compliant study was a 6-

181 erials and Methods This was an institutional review board-approved and HIPAA-compliant study.

182 multicenter, HIPAA-compliant, institutional review board-approved clinical trial was performed by ex

183 node resection (MLNR) under an Institutional Review Board-approved common protocol from 1992 to 2014.

184 uly 2012 to October 2013, this institutional review board-approved HIPAA-compliant prospective study

185 Materials and Methods In this institutional review board-approved HIPAA-compliant retrospective anal

186 Materials and Methods For this institutional review board-approved HIPAA-compliant retrospective stud

187 Materials and Methods This institutional review board-approved HIPAA-compliant retrospective stud

188 Materials and Methods In this institutional review board-approved HIPAA-compliant retrospective stud

189 Materials and Methods In this institutional review board-approved HIPAA-compliant retrospective stud

190 Materials and Methods For this institutional review board-approved HIPAA-compliant retrospective stud

191 This institutional review board-approved HIPAA-compliant retrospective stud

192 thods This was a retrospective institutional review board-approved HIPAA-compliant study.

193 = 19) and NHL (n = 2) onto the Institutional Review Board-approved investigation of (11)C-MET PET/CT.

194 = 19) and NHL (n = 2) onto the Institutional Review Board-approved investigation of (11)C-MET PET/CT.

195 hods For this HIPAA-compliant, institutional review board-approved prospective blinded pilot study, p

196 metastases were enrolled in an institutional review board-approved prospective clinical trial.

197 metastases were enrolled in an Institutional Review Board-approved prospective clinical trial.

198 Materials and Methods An institutional review board-approved prospective database of 257 patien

199 erials and Methods This was an institutional review board-approved prospective study in 29 patients (

200 ethods In this HIPAA-compliant institutional review board-approved prospective study in which all sub

201 Materials and Methods In this institutional review board-approved prospective study, 27 patients wit

202 oma (MP) were treated using an institutional review board-approved protocol.

203 thods In this HIPAA-compliant, institutional review board-approved retrospective cohort study, an ins

204 consisted of a HIPAA-compliant institutional review board-approved retrospective review of data in 16

205 Materials and Methods In this institutional review board-approved retrospective review of prospectiv

206 Materials and Methods An institutional review board-approved retrospective review was performed

207 Methods This HIPAA-compliant, institutional review board-approved retrospective study included 108 p

208 d Methods This HIPAA-compliant institutional review board-approved retrospective study included 159 p

209 Methods This HIPAA-compliant, institutional review board-approved retrospective study included 51 pa

210 Materials and Methods This institutional review board-approved retrospective study was performed

211 In this institutional review board-approved retrospective study, subjects were

212 Materials and Methods This institutional review board-approved retrospective study, with waived i

213 erials and Methods This was an institutional review board-approved retrospective study, with waiver o

214 nd genetic findings as part of institutional review board-approved studies at Children's National Hea

215 2010 to October 2012 for this institutional review board-approved study after they provided written

216 s prospective HIPAA-compliant, institutional review board-approved study between April 2012 and Novem

217 This institutional review board-approved study from June 2007 to December 2

218 Materials and Methods This institutional review board-approved study included 125 women with inva

219 and Methods This retrospective institutional review board-approved study included 24 patients with pr

220 Methods This HIPAA-compliant, institutional review board-approved study measured the performance of

221 and Methods This retrospective institutional review board-approved study received a waiver of informe

222 retrospective HIPAA-compliant institutional review board-approved study was exempt from informed con

223 itten informed consent in this institutional review board-approved study was obtained from eight heal

224 Methods This HIPAA-compliant, institutional review board-approved study was performed at a tertiary

225 prospective, HIPAA-compliant, institutional review board-approved study was performed by using the s

226 Methods In this retrospective, institutional review board-approved study, 120 patients who underwent

227 etrospective, HIPAA-compliant, institutional review board-approved study, 136 consecutive patients (9

228 ingle-center, HIPAA-compliant, institutional review board-approved study, 157 patients (86 men and 71

229 Materials and Methods In this institutional review board-approved study, 20 patients with chronic th

230 Methods In this retrospective, institutional review board-approved study, 33 patients who underwent a

231 Methods In this retrospective, institutional review board-approved study, 41 pediatric patients (age

232 Materials and Methods In this institutional review board-approved study, a public NSCLC data set tha

233 thods In this HIPAA-compliant, institutional review board-approved study, all patients with ADPKD pro

234 Materials and Methods In this institutional review board-approved study, all unenhanced DE head CT e

235 ods This was a HIPAA-compliant institutional review board-approved study, with informed consent from

236 Materials and Methods In this institutional review board-approved study, with the written informed c

237 vided informed consent in this institutional review board-approved study.

238 vided informed consent in this institutional review board-approved study.

239 nd maintained in a prospective institutional review board-approved study.

240 nstitution HIPAA-compliant and institutional review board-approved study.

241 ncluded in this retrospective, institutional review board-approved study.

242 itant CT were enrolled in this institutional review board-approved study.

243 ent prior to inclusion in this institutional review board-approved study.

244 pared in this HIPAA-compliant, institutional review board-approved study.

245 This study was institutional review board-approved with waivers of informed consent.

246 nd Methods In this binational, institutional review board-approved, HIPAA-compliant prospective study

247 This institutional review board-approved, HIPAA-compliant prospective study

248 er 2011 to September 2012 with institutional review board-approved, HIPAA-compliant protocols.

249 tireader, multi-institutional, institutional review board-approved, HIPAA-compliant retrospective ana

250 Materials and Methods This institutional review board-approved, HIPAA-compliant retrospective stu

251 and Methods This retrospective institutional review board-approved, HIPAA-compliant review of 7519 wo

252 Materials and Methods This institutional review board-approved, HIPAA-compliant study included 14

253 Materials and Methods In this institutional review board-approved, HIPAA-compliant study, 58 patient

254 In this institutional review board-approved, HIPAA-compliant study, a silicon

255 Materials and Methods For this institutional review board-approved, HIPAA-compliant study, thoracic e

256 hods This was a retrospective, institutional review board-approved, HIPAA-compliant study.

257 In an institutional review board-approved, HIPAA-compliant, prospective stud

258 Materials and Methods This institutional review board-approved, HIPAA-compliant, retrospective st

259 Materials and Methods This institutional review board-approved, HIPAA-compliant, retrospective st

260 In this institutional review board-approved, informed consent-waived, HIPAA-co

261 erials and Methods This was an institutional review board-approved, prospectively conducted (written

262 This is an Institutional Review Board-approved, retrospective study.

263 ials and Methods SIESTA was an institutional review board-approved, single-center, prospective, rando

264 tive HIPAA-compliant study was institutional review board-approved.

265 The institutional review board at each site approved the trial.

266 Materials and Methods The institutional review board exempted this HIPAA-compliant retrospective

267 An institutional review board exemption and a waiver for informed consent

268 Institutional review board exemptions were granted prior to the collec

269 obtained from the centralized institutional review board for this prospective single-arm study, and

270 tive study was approved by the institutional review board; informed consent was obtained from all pat

271 s research was approved by the institutional review board (IRB) and was HIPAA compliant.

272 protocol design, choice of an institutional review board (IRB), and trial outcomes.

273 r (TRD) who participated in an Institutional Review Board (IRB)-approved randomised double-blind tria

274 ethical review of research by institutional review boards (IRBs) due to the rush to enter the disast

275 Methods The study was approved by the local review board (NL42888.029.13).

276 The institutional review board of Beth Israel Deaconess Medical Center app

277 for the study was obtained from the ethical review board of the Netherlands Association for Medical

278 records review approved by the institutional review board of the University Health Network, Toronto.

279 The study was approved by the Institutional Review Board of the University Medical Center Groningen

280 tive study was approved by the institutional review board of the University of Wisconsin School of Me

281 tive study was approved by the institutional review board of three institutions.

282 Materials and Methods The institutional review boards of all participating centers approved this

283 Materials and Methods The institutional review boards of each center approved this retrospective

284 Materials and Methods The institutional review boards of the four participating centers approved

285 t protocol was approved by the institutional review boards of the participating centers.

286 om-based study was exempt from institutional review board oversight.

287 nography Materials and Methods Institutional review board permission was obtained to use deidentified

288 tients were collected under an institutional review board protocol 2 hours after portal reperfusion,

289 iew by the Columbia University Institutional Review Board, Protocol ID# AAAO3003.

290 The institutional review board provided a waiver of informed consent.

291 was compliant with the HIPAA (Institutional Review Board Reg. #00000940).

292 ed research, investigators and Institutional Review Boards should consider a deferred consent process

293 tive study was approved by the institutional review board; the requirement to obtain informed consent

294 The institutional review board waived the need for consent.

295 The institutional review board waived the requirement for informed consent

296 re exempted from review by the institutional review board, which consisted of 1007 posteroanterior ch

297 tive study was approved by the institutional review board, which waived the requirement for informed

298 iant study was approved by our institutional review board with a waiver of informed consent.

299 tive study was approved by the institutional review board with patient informed consent.

300 ticenter study was approved by institutional review boards with written informed consent.